| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Division of Gastroenterology and
Molecular Cardiovascular Research Center, Case Western Reserve University School of Medicine, Cleveland, OH 44106;
First Department of Internal Medicine, Nagoya University School of Medicine, Nagoya, Japan;
§
First Department of Surgery, Tohoku University School of Medicine, Sendai, Japan; and
¶
Department of Medicine, University of Toronto, Toronto, Canada
Crohn’s disease (CD) is a condition characterized by excessive
numbers of activated T cells in the mucosa. We investigated whether a
defect in apoptosis could prolong T cell survival and contribute to
their accumulation in the mucosa. Apoptotic, Bcl-2+, and
Bax+ cells in tissue sections were detected by the TUNEL
method and immunohistochemistry. T cell apoptosis was induced by IL-2
deprivation, Fas Ag ligation, and exposure to TNF-
and nitric oxide.
TUNEL+ leukocytes were few in control, CD, and ulcerative
colitis (UC) mucosa, with occasional CD68+ and
myeloperoxidase+, but no CD45RO+, apoptotic
cells. Compared with control and UC, CD T cells grew remarkably more in
response to IL-2 and were significantly more resistant to IL-2
deprivation-induced apoptosis. CD T cells were also more resistant to
Fas- and nitric oxide-mediated apoptosis, whereas TNF- failed to
induce cell death in all groups. Compared with control, CD mucosa
contained similar numbers of Bcl-2+, but fewer
Bax+, cells, while UC mucosa contained fewer
Bcl-2+, but more Bax+, cells. Hence, the
Bcl-2/Bax ratio was significantly higher in CD and lower in UC. These
results indicate that CD may represent a disorder where the rate of T
cell proliferation exceeds that of cell death. Insufficient T cell
apoptosis may interfere with clonal deletion and maintenance of
tolerance, and result in inappropriate T cell accumulation contributing
to chronic inflammation.
This article has been cited by other articles:
|
|
 |
|
  B. Weigmann and M. F Neurath Selective targeting of activated T cells in chronic intestinal inflammation Gut, June 1, 2009; 58(6): 747 - 748. [Full Text] [PDF]
|
|
|
|
|
|
S Shteingart, M Rapoport, I Grodzovski, O Sabag, M Lichtenstein, R Eavri, and H Lorberboum-Galski Therapeutic potency of IL2-caspase 3 targeted treatment in a murine experimental model of inflammatory bowel disease Gut, June 1, 2009; 58(6): 790 - 798. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F Caprioli, C Stolfi, R Caruso, D Fina, G Sica, L Biancone, F Pallone, and G Monteleone Transcriptional and post-translational regulation of Flip, an inhibitor of Fas-mediated apoptosis, in human gut inflammation Gut, December 1, 2008; 57(12): 1674 - 1680. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Caprioli, M. Sarra, R. Caruso, C. Stolfi, D. Fina, G. Sica, T. T. MacDonald, F. Pallone, and G. Monteleone Autocrine Regulation of IL-21 Production in Human T Lymphocytes J. Immunol., February 1, 2008; 180(3): 1800 - 1807. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. K. K. Tai, W. K. K. Wu, H. P. S. Wong, E. K. Y. Lam, L. Yu, and C. H. Cho A New Role for Cathelicidin in Ulcerative Colitis in Mice Experimental Biology and Medicine, June 1, 2007; 232(6): 799 - 808. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J M Watson In vivo single-photon emission computed tomography imaging of apoptosis in Crohn's disease and anti-tumour necrosis factor therapy Gut, April 1, 2007; 56(4): 461 - 463. [Full Text] [PDF]
|
|
|
|
|
|
J. M H Van den Brande, T. C Koehler, Z. Zelinkova, R. J Bennink, A. A te Velde, F. J W ten Cate, S. J H van Deventer, M. P Peppelenbosch, and D. W Hommes Prediction of antitumour necrosis factor clinical efficacy by real-time visualisation of apoptosis in patients with Crohn's disease Gut, April 1, 2007; 56(4): 509 - 517. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J Mudter and M F Neurath Apoptosis of T cells and the control of inflammatory bowel disease: therapeutic implications Gut, February 1, 2007; 56(2): 293 - 303. [Full Text] [PDF]
|
|
|
|
|
|
X Han, N Benight, B Osuntokun, K Loesch, S J Frank, and L A Denson Tumour necrosis factor {alpha} blockade induces an anti-inflammatory growth hormone signalling pathway in experimental colitis Gut, January 1, 2007; 56(1): 73 - 81. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Carol, N. Borruel, M. Antolin, M. Llopis, F. Casellas, F. Guarner, and J.-R. Malagelada Modulation of apoptosis in intestinal lymphocytes by a probiotic bacteria in Crohn's disease J. Leukoc. Biol., May 1, 2006; 79(5): 917 - 922. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Sodek, A. P. Batista Da Silva, and R. Zohar Osteopontin and Mucosal Protection Journal of Dental Research, May 1, 2006; 85(5): 404 - 415. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Ina, K. Kusugami, Y. Kawano, T. Nishiwaki, Z. Wen, A. Musso, G. A. West, M. Ohta, H. Goto, and C. Fiocchi Intestinal Fibroblast-Derived IL-10 Increases Survival of Mucosal T Cells by Inhibiting Growth Factor Deprivation- and Fas-Mediated Apoptosis J. Immunol., August 1, 2005; 175(3): 2000 - 2009. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. T. MacDonald, A. DiSabatino, and J. N. Gordon Immunopathogenesis of Crohn's Disease JPEN J Parenter Enteral Nutr, July 1, 2005; 29(4_suppl): S118 - S125. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Gassull, J. Mane, E. Pedrosa, and E. Cabre Macronutrients and Bioactive Molecules: Is There a Specific Role in the Management of Inflammatory Bowel Disease? JPEN J Parenter Enteral Nutr, July 1, 2005; 29(4_suppl): S179 - S183. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Quadrilatero and L. Hoffman-Goetz N-acetyl-l-cysteine protects intestinal lymphocytes from apoptotic death after acute exercise in adrenalectomized mice Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2005; 288(6): R1664 - R1672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Clark, R. H. Lane, N. K. MacLennan, H. Holubec, K. Dvorakova, M. D. Halpern, C. S. Williams, C. M. Payne, and B. Dvorak Epidermal growth factor reduces intestinal apoptosis in an experimental model of necrotizing enterocolitis Am J Physiol Gastrointest Liver Physiol, April 1, 2005; 288(4): G755 - G762. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M P Peppelenbosch and S J H van Deventer T cell apoptosis and inflammatory bowel disease Gut, November 1, 2004; 53(11): 1556 - 1558. [Full Text] [PDF]
|
|
|
|
|
|
A Sturm, A Z A Leite, S Danese, K A Krivacic, G A West, S Mohr, J W Jacobberger, and C Fiocchi Divergent cell cycle kinetics underlie the distinct functional capacity of mucosal T cells in Crohn's disease and ulcerative colitis Gut, November 1, 2004; 53(11): 1624 - 1631. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J Doering, B Begue, M J Lentze, F Rieux-Laucat, O Goulet, J Schmitz, N Cerf-Bensussan, and F M Ruemmele Induction of T lymphocyte apoptosis by sulphasalazine in patients with Crohn's disease Gut, November 1, 2004; 53(11): 1632 - 1638. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Sturm, M. Lensch, S. Andre, H. Kaltner, B. Wiedenmann, S. Rosewicz, A. U. Dignass, and H.-J. Gabius Human Galectin-2: Novel Inducer of T Cell Apoptosis with Distinct Profile of Caspase Activation J. Immunol., September 15, 2004; 173(6): 3825 - 3837. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Zeissig, C Bojarski, N Buergel, J Mankertz, M Zeitz, M Fromm, and J D Schulzke Downregulation of epithelial apoptosis and barrier repair in active Crohn's disease by tumour necrosis factor {alpha} antibody treatment Gut, September 1, 2004; 53(9): 1295 - 1302. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. ten Hove, F. O. The, M. Berkhout, J. P. Bruggeman, F. A. Vyth-Dreese, J. F. M. Slors, S. J. H. van Deventer, and A. A. te Velde Expression of CD45RB functionally distinguishes intestinal T lymphocytes in inflammatory bowel disease J. Leukoc. Biol., June 1, 2004; 75(6): 1010 - 1015. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Schade and A. D. Levine Cutting Edge: Extracellular Signal-Regulated Kinases 1/2 Function as Integrators of TCR Signal Strength J. Immunol., May 15, 2004; 172(10): 5828 - 5832. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Stallmach, T Marth, B Weiss, B M Wittig, A Hombach, C Schmidt, M Neurath, M Zeitz, S Zeuzem, and H Abken An interleukin 12 p40-IgG2b fusion protein abrogates T cell mediated inflammation: anti-inflammatory activity in Crohn's disease and experimental colitis in vivo Gut, March 1, 2004; 53(3): 339 - 345. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Schwarz, E. Tutsch, B. Ludwig, E. C. Schwarz, A. Stallmach, and M. Hoth Ca2+ Signaling in Identified T-lymphocytes from Human Intestinal Mucosa: RELATION TO HYPOREACTIVITY, PROLIFERATION, AND INFLAMMATORY BOWEL DISEASE J. Biol. Chem., February 13, 2004; 279(7): 5641 - 5647. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Lu, M. S. Caplan, A. P. Saraf, D. Li, L. Adler, X. Liu, and T. Jilling Platelet-activating factor-induced apoptosis is blocked by Bcl-2 in rat intestinal epithelial cells Am J Physiol Gastrointest Liver Physiol, February 1, 2004; 286(2): G340 - G350. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Di Sabatino, R Ciccocioppo, B Cinque, D Millimaggi, R Morera, L Ricevuti, M G Cifone, and G R Corazza Defective mucosal T cell death is sustainably reverted by infliximab in a caspase dependent pathway in Crohn's disease Gut, January 1, 2004; 53(1): 70 - 77. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Marini, G. Bamias, J. Rivera-Nieves, C. A. Moskaluk, S. B. Hoang, W. G. Ross, T. T. Pizarro, and F. Cominelli TNF-{alpha}neutralization ameliorates the severity of murine Crohn's-like ileitis by abrogation of intestinal epithelial cell apoptosis PNAS, July 8, 2003; 100(14): 8366 - 8371. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N Borruel, M Carol, F Casellas, M Antolin, F de Lara, E Espin, J Naval, F Guarner, and J R Malagelada Increased mucosal tumour necrosis factor {alpha} production in Crohn's disease can be downregulated ex vivo by probiotic bacteria Gut, November 1, 2002; 51(5): 659 - 664. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S J H van Deventer Anti-tumour necrosis factor therapy in Crohn's disease: where are we now? Gut, September 1, 2002; 51(3): 362 - 363. [Full Text]
|
|
|
|
|
|
I Monteleone, P Vavassori, L Biancone, G Monteleone, and F Pallone Immunoregulation in the gut: success and failures in human disease Gut, May 1, 2002; 50(90003): iii60 - 64. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Sturm and C Fiocchi Life and death in the gut: more killing, less Crohn's Gut, February 1, 2002; 50(2): 148 - 149. [Full Text] [PDF]
|
|
|
|
|
|
T ten Hove, C van Montfrans, M P Peppelenbosch, and S J H van Deventer Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease Gut, February 1, 2002; 50(2): 206 - 211. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A DI SABATINO and G R CORAZZA Surviving too long in Crohn's disease Gut, July 1, 2001; 49(1): 6 - 8. [Full Text] [PDF]
|
|
|
|
|
|
J Itoh, C de la Motte, S A Strong, A D Levine, and C Fiocchi Decreased Bax expression by mucosal T cells favours resistance to apoptosis in Crohn's disease Gut, July 1, 2001; 49(1): 35 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Bu, A. Keshavarzian, D. D. Stone, J. Liu, P. T. Le, S. Fisher, and L. Qiao Apoptosis: One of the Mechanisms That Maintains Unresponsiveness of the Intestinal Mucosal Immune System J. Immunol., May 15, 2001; 166(10): 6399 - 6403. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P DESREUMAUX Specific targeting of IL-6 signalling pathway: a new way to treat IBD? Gut, October 1, 2000; 47(4): 465 - 466. [Full Text] [PDF]
|
|
|
|
|
|
M. J. Pinkoski, T. Brunner, D. R. Green, and T. Lin Fas and Fas ligand in gut and liver Am J Physiol Gastrointest Liver Physiol, March 1, 2000; 278(3): G354 - G366. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
